The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

November 2021

Volume 17 Number 10

In this special PCR London Valves edition, the EuroIntervention State-of-the-Art is on the endovascular treatment of tricuspid valve disease and tricuspid regurgitation. The mini focus is also on tricuspid regurgitation with an article on the TriBAND post-market clinical follow-up study evaluating the safety and effectiveness of the Cardioband tricuspid valve reconstruction system; transcatheter tricuspid valve replacement using the novel LuX-Valve; the impact of mitral valve repair with the MitraClip on tricuspid regurgitation. An expert review on the possibilities of coronary access after TAVI; a comparison of outcomes in valve-in-valve procedures with or without bioprosthetic valve fracture; preclinical research on implanting transcatheter heart valves; and more.

Highlights from this issue

The TriBAND study 30-day outcomes
The TriBAND study 30-day outcomes
Nickenig G, Friedrichs K, Baldus S, Arnold M, Seidler T, Hakmi S, Linke A, Schäfer U, Dreger H, Reinthaler M, von Bardeleben R, Möllmann H, Weber M, Roder F, Körber M, Landendinger M, Wolf F, Alessandrini H, Sveric K, Schewel D, Romero-Dorta E, Kasner M, Dahou A, Hahn R, Windecker S
November 19, 2021
DOI: 10.4244/EIJ-D-21-00300
Outcome of VIV-TAVI with and without BVF
Outcome of VIV-TAVI with and without BVF
Brinkmann C, Abdel-Wahab M, Bedogni F, Bhadra O, Charbonnier G, Conradi L, Hildick-Smith D, Kargoli F, Latib A, Van Mieghem N, Mylotte D, Landes U, Pilgrim T, Stripling J, Taramasso M, Tchétché D, Testa L, Thiele H, Webb J, Windecker S, Witt J, Wohlmuth P, Schofer J
November 19, 2021
DOI: 10.4244/EIJ-D-21-00254
Redo TAVI
Redo TAVI
Sathananthan J, Fraser R, Landes U, Rich C, Sellers S, Leipsic J, Blanke P, Lutter G, Frank D, Puehler T, Wood D, Søndergaard L, Webb J
November 19, 2021
DOI: 10.4244/EIJ-D-20-00697